Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02665195 · ClinicalTrials.gov registry record
Prospective Registry of Multiplex Testing (PROMPT)
A clinical trial of Genetic Testing, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 689
- Enrollment target
- 10
- Study locations
NCT02665195: Active study of Genetic Testing, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02665195 is a study of Genetic Testing that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 689 participants, above the 548-participant average among 7 other Genetic Testing trials with a reported enrollment target (26% higher). The trial reports 10 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02665195, a study of Genetic Testing, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 689 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is being done to learn more about how changes in certain genes may be linked to cancer. Some people with cancer got their disease because they inherited an abnormal (mutated) gene. The researchers of this study want to better understand the risks that are linked to genetic changes in these less well-studied genes. By understanding these risks, we believe that doctors will be able to give better advice to families with mutations in these genes.
Conditions Studied
Interventions
- OTHER saliva specimen
- BEHAVIORAL questionnaire
Study Locations (10)
New York
- Memorial Sloan Kettering Cancer Center @ Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering @ Rockville - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Massachusetts
- Dana Farber Cancer Institute - Boston
Minnesota
- Mayo Clinic Cancer Center - Rochester
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 689 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-01 |
What the registry record for NCT02665195 still lists
NCT02665195 is an observational study that tracks outcomes without assigning an intervention. The registered 689 participants enrollment target is mid-sized for trials with a published cap, above the 548-participant average among 7 other Genetic Testing trials with a reported enrollment target (26% higher).
The record links to 1 condition, with Genetic Testing appearing as the primary indexed condition, and to 2 interventions - of which saliva specimen is the first listed.
NCT02665195 lists 10 locations in 5 states (New York, New Jersey, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02665195 about?
NCT02665195 is a clinical study titled "Prospective Registry of Multiplex Testing (PROMPT)". This study is being done to learn more about how changes in certain genes may be linked to cancer. Some people with cancer got their disease because they inherited an abnormal (mutated) gene. The researchers of this study want to better understand the risks that are linked to genetic changes in the...
What is the current status of trial NCT02665195?
This trial is currently active not recruiting. The enrollment target is 689 participants. The study started on 2016-01. Estimated completion is 2027-01.
What conditions does trial NCT02665195 study?
This clinical trial studies the following conditions: Genetic Testing.
What interventions are being tested in trial NCT02665195?
The interventions under investigation include: saliva specimen (OTHER), questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02665195?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02665195 being conducted?
This trial has 10 study locations across Massachusetts, Minnesota, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Testing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
RECRUITING
-
Comparing Direct vs Indirect Methods for Cascade Screening
RECRUITING · NA
-
Addressing Genomic Disparities in Cancer Survivors
RECRUITING · NA
-
Universal Genetic Testing for Cancer Risk Reduction
RECRUITING · NA
-
Video Education With Result Dependent dIsclosure
RECRUITING · NA
-
Engaging Adolescents in Decisions About Return of Genomic Research Results
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00532051 · 690 participants
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
- NCT05184335 · 690 participants · Phase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- NCT07221149 · 690 participants · Phase 2
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- NCT05750654 · 688 participants · NA
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia